歡迎網友自由發表文章，但嚴禁發表有關相互人身攻擊言論、廣告文章、任何交易買賣 、或與本站主題不相關的文章。
請勿連續發表相同文章，關於討論區內的所有文章，本站皆擁有刪除及修改文章的權利。

回應討論主題
回應主題：
您的稱呼：
您的性別：
您的職業：
來自何方：
電子信箱：
您的首頁：
留言筆色：
討論內容： What part of do you come from? blog writing services packages The company is braced for fines in China. And, since it is fairly clear that the Chinese government is thinking about how to reform the structure and practices of its health service - especially how pharmaceuticals are procured and how much is paid for them - GSK is mulling whether it can make a gesture that would be seen to support such reforms.

留言內容：